Shares of Glenmark Pharmaceuticals struck a fresh high
Advertisement
Advertisement
Glenmark said its US unit has been granted final approval by the United States Food and Drug Administration for Drospirenone and Ethinyl Estradiol Tablets USP, 3mg/0.02 mg, the generic version of Yaz Tablets of Bayer HealthCare Pharmaceuticals Inc.
As a consequence, Glenmark added 50 rupees, or 4.4 percent, to 1209.80 rupees on the National Stock Exchange where 11 lakh shares were traded compared with a 5-day average of 16.6 lakh shares.
Glenmark's market capitalisation has gained 68 percent in the past one year to 33,800 crore rupees as investors preferred the relative predictability of pharma revenues. The stock trades 8 times book value of 146 rupees.
Image credit: Indiatimes
Advertisement
Advertisement
- Some Tesla factory workers realized they were laid off when security scanned their badges and sent them back on shuttles, sources say
- I tutor the children of some of Dubai's richest people. One of them paid me $3,000 to do his homework.
- India not benefiting from democratic dividend; young have a Kohli mentality, says Raghuram Rajan
- Indo-Gangetic Plains, home to half the Indian population, to soon become hotspot of extreme climate events: study
- 7 Vegetables you shouldn’t peel before eating to get the most nutrients
- Gut check: 10 High-fiber foods to add to your diet to support digestive balance
- 10 Foods that can harm Your bone and joint health
- 6 Lesser-known places to visit near Mussoorie